Immune Design: Big Pharma rescues flailing 'cancer vaccine' company with $300 million buyout
The deal comes four months after Immune Design Corp. halted its lead cancer vaccine trial and restructured its drug development plans.
Read full article »
Immune Design develops immunotherapy product candidates for the treatment of cancer and chronic diseases.
Read more